NEFL and Parkinson disease: Therefore, blood NfL has been described as promising surrogate parameter for several important clinical questions, such as marker for disease severity and an indicator for disease duration of PD subtypes (Hansson et al. 2017; Khalil et al. 2018; Lin et al. 2019; Mollenhauer et al. 2020; Ng et al. 2020).